Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Comparative real-world survival of first-line atezolizumab, nivolumab, and pembrolizumab in older patients with metastatic non-small cell lung cancer.
Journal: Journal of managed care & specialty pharmacy
Published: October 31, 2025
Cost-effectiveness of cemiplimab plus chemotherapy vs pembrolizumab plus chemotherapy as first-line treatment for advanced non-small cell lung cancer.
Journal: Journal of managed care & specialty pharmacy
Published: February 06, 2025
Comparative effectiveness and safety of eribulin in advanced or metastatic breast cancer: a systematic review and meta-analysis.
Journal: Critical reviews in oncology/hematology
Published: March 02, 2021
Establishment of the Alabama Hereditary Cancer Cohort - strategies for the inclusion of underrepresented populations in cancer genetics research.
Journal: Molecular genetics & genomic medicine
Published: March 26, 2018
Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer.
Journal: American journal of clinical oncology
Published: May 25, 2017
Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: December 15, 2015
Treatment patterns among breast cancer patients in the United States using two national surveys on visits to physicians' offices and hospital outpatient departments.
Journal: Research in social & administrative pharmacy : RSAP
Published: October 17, 2014
Showing 1-7 of 7
Last Updated: 09/26/2026